GL1X · GenesisL1 explorer

MolNFT v1 · #125768 · protein

Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319

5LIW · Aldo-keto reductase family 1 member B10: “Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319”. X-ray diffraction, 2 ligands (1WX, NAP), 2 pockets (best druggability 0.78). MolNFT v1 #125768 on GenesisL1…

PDB
5LIW
Type
protein
Length
316 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldo-keto reductase family 1 member B10
EC
1.1.1.-
UniProt
O60218
Ligands
1WX, NAP
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XAldo-keto reductase family 1 member B10 (EC 1.1.1.-)protein31636% helix, 16% strandO60218

Ligands and binding sites

  • 1WX · {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid · ligand · 2 copies · chains X
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains X
  • EDO · 1,2-ethanediol · additive · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15350.780.8554NAP, 1WX
2680.430.8218empty

Modifications

Observed in the structure: 9 modified (methylation).

Compared structures

  • 5LIW · Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319 · the same entry in another collection · chain X against X, TM-score 1.00
  • O60218 · AlphaFold monomer V2.0 prediction for aldo-keto reductase family 1 member B10 (O60218) · a predicted model of the same protein · chain X against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.